P21
P21Neurogenic peptide studied in cognition.
Also known as: P021, Ciliary neurotrophic factor peptide
Overview
P21 is a small peptide studied in neurogenesis and cognition research, derived from a neurotrophic-factor active region.
An experimental peptide derived from research on Cerebrolysin's active fragments, studied for promoting neurogenesis (new neuron formation) and upregulating BDNF. Research interest centers on cognitive enhancement and neuroprotection via the same neurotrophic pathways.
Studied for mimicking neurotrophic-factor activity, promoting neurogenesis and increasing BDNF signaling.
Molecular information
Designed to mimic the neurotrophic activity of Cerebrolysin in a defined small peptide.
Pharmacokinetics
Illustrative relative-concentration model derived from published pharmacokinetic research. Curve is normalized and provided for educational comparison only — not a dosing schedule.
Research applications
- Neurogenesis research
- Cognitive-enhancement studies
- Neurotrophic investigations
Research protocols
Protocols summarized from published research models. Provided for scientific reference only — not dosing guidance for human use.
Observed effects timeline
Aggregated observations reported across research literature. Timing and magnitude vary by model and are not a guarantee of outcome.
Week 1–4
Neurogenic and BDNF-related signaling reported in study models.
Week 4–12
Cognitive and neuroprotective changes reported with continued use.
Research compatibility
Describes how compounds are studied alongside one another in the literature. Not a recommendation to co-administer.
Dihexa
Complementary synaptogenic/neurotrophic pathways.
Semax
Complementary BDNF-related nootropic pathways.
Cerebrolysin
P21 is derived from Cerebrolysin activity ��� overlapping mechanism.
How to reconstitute
Reconstitute with bacteriostatic water, swirl gently, and refrigerate. Avoid shaking to preserve the peptide.
- 1Allow the vial to reach room temperature (15–20 minutes).
- 2Swab the stopper with alcohol and let it air dry.
- 3Add bacteriostatic water slowly down the vial wall.
- 4Swirl gently until dissolved into a clear solution.
- 5Refrigerate at 2–8 °C and protect from light.
Quality indicators
Uniform white powder
Lyophilized cake should be white to off-white without discoloration.
Clear solution
Reconstitutes to a clear, colorless, particle-free solution.
Cold-chain integrity
Reconstituted solution requires 2–8 °C storage.
Slight clumping
Small clumps that dissolve completely with gentle swirling are acceptable — shipping can cause minor compaction.
Collapsed or melted appearance
Powder that looks collapsed, melted, or stuck to the vial walls may have been exposed to heat in transit.
Cloudy after reconstitution
Persistent cloudiness, particles, or precipitate after gentle mixing can indicate a degraded or contaminated peptide.
Reported observations & safety
Safety signals reported in the research literature. Compiled for scientific awareness — not medical advice.
- Human data are essentially absent; evidence is preclinical and the peptide is experimental.
- Generally reported as well tolerated at research amounts in animal models.
References & further reading
Cerebrolysin-derived peptides and neurogenesis (preclinical)
Research on Cerebrolysin-derived peptide fragments and their neurogenic and neurotrophic activity.
View studyTopics
This entry is provided for educational and informational purposes only. It is not medical advice, a dosing protocol, or a claim of therapeutic benefit. Research compounds are supplied strictly for laboratory and research use — not for human or veterinary consumption.
Active but early-stage research; evidence still developing.
This compound is part of our educational reference and is not currently stocked. Browse the catalogue for available research-grade peptides.
Browse catalogue
